Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells

被引:48
作者
Huang, Hai
Chan, Herman
Wang, Yuan-Yuan
Ouyang, Dong-Yun
Zheng, Yong-Tang
Tam, Siu-Cheung [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Acad Sci, Kunming Inst Zool, Lab Mol Immunopharmacol, Kunming 650223, Peoples R China
[3] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
基金
中国国家自然科学基金;
关键词
trichosanthin; HSV-1; MAPK; Bcl-2; antiviral activity;
D O I
10.1016/j.lfs.2006.03.047
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Trichosanthin (TCS) is a type I ribosome-inactivating protein (RIP) effective against HIV-1 and HSV-1 replication. The mechanism of its antiviral activity is not clear. Many believe that it is related to ribosome inactivation. Some RIPs and viral infection affect the phosphorylation of MAPK and Bcl-2 and these proteins may be the common element linking RIP and viral infection. This study investigated the effect of HSV-1 infection on p38 MAPK and Bcl-2 as well as possible interference by TCS. Results showed that HSV-1 infection induced an elevation of phosphorylated p38 and Bcl-2 in Vero cells, which could be partially blocked by TCS. At the same time, both viral replication and host cells viability were lowered. Viral replication, Vero cell viability, p38 MAPK and Bcl-2 were further reduced with the addition of a p38 MAPK inhibitor (SB203580). This suggested that TCS may interfere with MAPK and Bcl-2 signals generated by infection leading to inhibition of viral replication. In summary, our results demonstrated that HSV-1 infection in Vero cells induced an elevation of p38 MAPK and Bcl-2. TCS suppressed this rise and reduced viral replication. The MAPK family may play a role in the antiviral mechanism of TCS. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1287 / 1292
页数:6
相关论文
共 29 条
[1]
The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]
A PHASE-I/II STUDY OF TRICHOSANTHIN TREATMENT OF HIV DISEASE [J].
BYERS, VS ;
LEVIN, AS ;
WAITES, LA ;
STARRETT, BA ;
MAYER, RA ;
CLEGG, JA ;
PRICE, MR ;
ROBINS, RA ;
DELANEY, M ;
BALDWIN, RW .
AIDS, 1990, 4 (12) :1189-1196
[3]
A PHASE-II STUDY OF EFFECT OF ADDITION OF TRICHOSANTHIN TO ZIDOVUDINE IN PATIENTS WITH HIV DISEASE AND FAILING ANTIRETROVIRAL AGENTS [J].
BYERS, VS ;
LEVIN, AS ;
MALVINO, A ;
WAITES, L ;
ROBINS, RA ;
BALDWIN, RW .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :413-420
[4]
CARTRY G, 1997, 23 ICPIG TOUL 17 22, V2, P71
[5]
Lowering of trichosanthin immunogenicity by site-specific coupling to dextran [J].
Chan, WL ;
Shaw, PC ;
Li, XB ;
Xu, QF ;
He, XH ;
Tam, SC .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (08) :927-934
[6]
Relationship between trichosanthin cytotoxicity and its intracellular concentration [J].
Chan, WL ;
Zheng, YT ;
Huang, H ;
Tam, SC .
TOXICOLOGY, 2002, 177 (2-3) :245-251
[7]
Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[8]
Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner [J].
Galvan, V ;
Roizman, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3931-3936
[9]
Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed PEGylation [J].
He, XH ;
Shaw, PC ;
Tam, SC .
LIFE SCIENCES, 1999, 65 (04) :355-368
[10]
Ribotoxic stress response: Activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA [J].
Iordanov, MS ;
Pribnow, D ;
Magun, JL ;
Dinh, TH ;
Pearson, JA ;
Chen, SLY ;
Magun, BE .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (06) :3373-3381